Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
03/2003
03/12/2003CN1401661A Radio-labeled compound for imaging of thrombus
03/11/2003US6531573 Histatin-based peptides; amino acid sequences; use treat fungal and bacterial infections in mammals
03/11/2003US6531572 Metal chelate-labelled peptides
03/11/2003US6531451 Isolated antigenic peptide consisting of specified amino acid sequence
03/11/2003US6531446 Peptides having biological activity
03/11/2003US6531138 Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypetides and peptides in the diagnostic of tuberculosis
03/11/2003US6531127 Useful for diagnostic purposes for identifying specific antibodies against human papillomavirus 16 E1 or E2 protein, which contains polypeptides with specific amino acid sequece
03/11/2003CA2050216C Process for the preparation of peptides by solid-phase synthesis
03/06/2003WO2003019195A2 Cellular immunity test with peptides fixed on a solid support
03/06/2003WO2003018758A2 Reagents and methods for smooth muscle therapies
03/06/2003WO2003018636A2 Chimaeric peptides of insulin, their compositions and use in treating diabetes
03/06/2003WO2003018619A2 Antimicrobial and anti-inflammatory peptides
03/06/2003WO2003018618A2 Catalysis of the cis/trans isomerisation of secondary amide peptide compounds
03/06/2003WO2003018615A1 Novel crystal of cyclic lipopeptide compound
03/06/2003WO2003018611A2 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
03/06/2003WO2003018606A2 Casein derived peptides and uses thereof in therapy
03/06/2003WO2003017924A2 Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
03/06/2003WO2002081683A3 Protein analysis by means of immobilized arrays of antigens or antibodies
03/06/2003WO2001086293A8 A method for designing and screening random libraries of compounds
03/06/2003WO2001077146A3 Compounds and methods for modulating endothelial cell adhesion
03/06/2003US20030045694 Ultra-sensitive detection systems
03/06/2003US20030045680 Peptidic modulators of the androgen receptor
03/06/2003US20030045678 Crystalline or crystal-like lipopeptide for use as bactericides
03/06/2003US20030045484 Crystallizing amorphous daptomycin from a crystallization solution comprising a cation from a salt, a buffer, an organic precipitant, and a low molecular weight alcohol.
03/06/2003US20030045477 Peptides having antiangiogenic activity
03/06/2003US20030045476 Heart homing conjugates
03/06/2003US20030045475 Reducing the rate of islet cell infiltration by lymphocytes in a diabetes-susceptible mammal by administering a gonadotropin-releasing hormone antagonist.
03/06/2003US20030045465 RTransport polymer comprising a linear or branched peptide having 10-300 amino acid residues, having from about 5 to 100% histidine residues; drug delivery, especially gene therapy and cancer chemotherapy
03/06/2003US20030045460 Orally administered peptides to ameliorate atherosclerosis
03/06/2003US20030044936 Peptide repeat immunogens
03/06/2003US20030044851 Secreted protein HCEJQ69
03/06/2003US20030044838 Generation of peptides which bind bacterial spores; btain phage, incubate with spore, centrifuge, wash, elute, amplify eluted phage, purifying clones, amplify clones, extract nucleotide sequences incubate with peptide, monitor binding
03/06/2003CA2458986A1 Cellular immunity test with peptides fixed on a solid support
03/06/2003CA2458924A1 Casein derived peptides and uses thereof in therapy
03/06/2003CA2458866A1 Compositions and methods of treating diabetes
03/06/2003CA2458574A1 Reagents and methods for smooth muscle therapies
03/06/2003CA2457903A1 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
03/06/2003CA2457885A1 Antimicrobial and anti-inflammatory peptides
03/06/2003CA2456323A1 Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
03/05/2003EP1288224A1 Therapeutic peptide derivatives
03/05/2003EP1288223A1 Therapeutic peptide derivatives
03/05/2003EP1288222A1 Peptidic compounds selectively binding to P-selectin
03/05/2003EP1288221A1 Oligopeptides
03/05/2003EP1287831A1 Antigen mimotopes and vaccine against cancerous diseases
03/05/2003EP1287034A2 Derivatives of breast cancer antigen her-2 for therapeutical use
03/05/2003EP1286684A2 Cxcr4 antagonist treatment of hematopoietic cells
03/05/2003EP1286590A2 Peptide analogs and mimetics suitable for in vivo use in the treatment of diseases associated with abnormal protein folding into amyloid, amyloid-like deposits or beta-sheet rich pathological precursor thereof
03/05/2003EP0942901B1 Cyclic imines as pesticides
03/05/2003EP0845034B1 peptide having pronociceptive properties
03/05/2003EP0822827B1 Antagonists of lhrh
03/05/2003EP0656952B1 Cationic peptides and method for production
03/05/2003CN1400218A Biological active peptide whose sequence number is 19
03/05/2003CN1400217A Biological active peptide whose sequence number is 20
03/05/2003CN1102598C Peptides derived from human heat shock protein 60, compositions and application thereof
03/04/2003US6528619 Cyclic peptide binding inhibitors; structural formulas; use drugs for diseases mediated by urokinase and receptor; tumors; inflammation; angiogenesis
03/04/2003US6528487 Including GMP-140, ELAM-1, and lymphocyte-homing receptor.
03/04/2003US6528481 NG2/HM proteoglycan-binding peptides that home to angiogenic vasculature and related methods
03/04/2003US6528275 Substrates and inhibitors of proteolytic enzymes
03/04/2003US6528093 Sustained-release preparation
03/04/2003US6528060 Therapeutic compounds
03/04/2003US6528054 Comprise one or more breast tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions. Alternatively, a therapeutic composition may comprise an antigen presenting cell that expresses a breast
02/2003
02/27/2003WO2003016561A2 Method for the production of cna
02/27/2003WO2003016496A2 Zinc finger binding domains for cnn
02/27/2003WO2003016351A2 N - cam related compounds modulating cell groth
02/27/2003WO2003016331A2 Non-mammalian gnrh analogs and uses thereof in regulation of fertility and pregnancy
02/27/2003WO2003015820A1 GnRH AGONIST COMBINATION DRUGS
02/27/2003WO2002083713A3 Echinocandin process
02/27/2003WO2002078597A3 Oral absorbed drugs
02/27/2003WO2002074794A3 Compositions useful in gene therapy
02/27/2003WO2002055555A3 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same
02/27/2003WO2002055022A3 Active metabolite of antifungal compound
02/27/2003WO2002049577A3 Analogues of thiocoraline and be-22179
02/27/2003WO2002006308A3 Methods for promoting dendritic cell proliferation or differentiation
02/27/2003WO2001097861A3 Vitronectin receptor antagonist pharmaceuticals
02/27/2003WO2001097860A3 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy
02/27/2003US20030040483 Compounds with growth hormone releasing properties
02/27/2003US20030040482 For therapy of precocious puberty, prostate cancer, ovarian cancer, benign prostatic hypertrophy, endometriosis, uterine fibroids, breast cancer, premenstrual syndrome, polycystic ovary syndrome, disease caused by excesses of gonadal hormones
02/27/2003US20030040472 Novel peptide conjugates
02/27/2003US20030040470 For therapy of hypercholesterolemia, viral infection
02/27/2003US20030039698 Sustained-release preparation
02/27/2003CA2457164A1 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival of cells
02/26/2003EP1285928A1 Antibiotics tripropeptins and process for producing the same
02/26/2003EP1285000A2 Use of adnf for enhancing learning and memory
02/26/2003EP1284997A2 Therapeutic compounds for ovarian cancer
02/26/2003EP1284996A2 Therapeutic anti-melanoma compounds
02/26/2003EP0941235B1 Cyclic peptides that bind to urokinase-type plasminogen activator receptor
02/26/2003EP0832068B1 Stable reagents for the preparation of radiopharmaceuticals
02/26/2003CN1399561A Conjugate having cleavable linkage for use in liposome
02/26/2003CN1398897A Serial synthetic antibacterial peptide
02/26/2003CN1398895A Hypoxic inducing factor-1 relative peptide and its screening
02/26/2003CN1398894A Bioactive peptide No.26
02/26/2003CN1398893A Bioactive peptide No.27
02/26/2003CN1398892A Bioactive peptide No.28
02/26/2003CN1398891A Bioactive peptide No.12
02/26/2003CN1398890A Bioactive peptide No.13
02/26/2003CN1398889A Bioactive peptide No.18
02/26/2003CN1398888A Bioactive peptide No.29
02/26/2003CN1398887A Bioactive peptide No.11
02/26/2003CN1398886A Bioactive peptide No.17
02/26/2003CN1398885A Bioactive peptide No.7
1 ... 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 ... 423